Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Onconova Therapeutics Inc (NASDAQ:ONTX)

0.55
Delayed Data
As of Feb 05
 +0.02 / +3.77%
Today’s Change
0.32
Today|||52-Week Range
4.00
-42.52%
Year-to-Date
No recent news for Onconova Therapeutics Inc.

Today’s Trading

Previous close0.53
Today’s open0.51
Day’s range0.46 - 0.63
Volume25,767
Average volume (3 months)165,938
Market cap$13.2M
Dividend yield--
Data as of 3:58pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+51.96%
Earnings growth (this year)+49.32%
Earnings growth (next 5 years)--
Revenue growth (last year)-83.17%
P/E ratioNM
Price/Sales89.05
Price/Book0.51

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...-0.01-3.90%
NEOTNeothetics Inc----
IMNPImmune Pharmaceutica...-0.01-2.33%
OPXAOpexa Therapeutics I...+0.01+0.50%
Data as of 3:59pm ET, 02/05/2016

Financials

Next reporting dateMarch 24, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$800.0K
Annual profit (last year)-$63.7M
Net profit margin-7,960.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ramesh Kumar
Chief Financial Officer &
Secretary
Ajay Bansal
Corporate headquarters
Newtown, Pennsylvania

Forecasts

Partner Offers